Lila Delbos

Lila Delbos

Auto-generated profile, based on publicly available information

Lila Delbos

Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Médicaments (CiTCoM); Paris, F-75006, France

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BBBruno Bonnettaz
Bruno Bonnettaz
ASAnna Smirnova
Anna Smirnova
MVMarlene Vayssieres
Marlene Vayssieres
LDLila Delbos
Lila Delbos
EZEmilie Zelie
Emilie Zelie
Alexandre SmirnovAlexandre Smirnov
Alexandre Smirnov
All living beings use ribosomes to synthesize proteins from α-amino acids. Inherited from our common ancestor, a few universally conserved ribosome biogenesis steps, introducing essential ribosomal RNA modifications, have survived to our days. However, it was unknown whether similar primordial core mechanisms could also target ribosomal proteins. Here we show that the assembly and the function of ribosomes depend on the installation of an unusual β-amino acid, isoaspartate, within the ribosomal protein uS11. In bacteria, mitochondria, and plastids, this modification is catalyzed by the metzincin-like hydrolase YbeY, whereas in archaea and eukaryotes, it is introduced by the atypical kinase Fap7. The formation of this strategically positioned isoaspartate enables correct maturation of the small ribosomal subunit to support protein synthesis and normal cell physiology.

20 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
WLWangqing Liu
Wangqing Liu
MZMengmeng Zhang
Mengmeng Zhang
YKYelda Abou Khalil
Yelda Abou Khalil
LDLila Delbos
Lila Delbos
NLNicolas Leulliot
Nicolas Leulliot
MBMagali Blaud
Magali Blaud
Fap7 is an assembly factor involved in ribosome biogenesis ensuring the correct incorporation of the ribosomal protein uS11 into the ribosome. In addition, human Fap7 (hFap7) acts as the upstream regulator of tumor suppresser p53 signaling through uS11-HDM2-p53 pathway. In recent years, hFap7 has attracted increasing interest due to its overexpression in various cancers and is considered as a potential anticancer target. However, to date, no inhibitors targeting hFap7 have been reported.In this study, we developed a practical and robust fluorescence polarization (FP) assay for high-throughput screening of inhibitors that disrupt the hFap7-uS11 interaction. A fluorescent probe derived from C-terminus of human uS11 was designed based on hFap7-uS11 complex structure predicted by AlphaFold3. We subsequently evaluated the effects of NaCl concentration, buffer type, ADP/Mg2+ and Tween-20 on the complex formation. The optimized screening condition was established as follows: 50 nM fluorescent probe, 250 nM His-hFap7 (in the presence of 2.5 µM ADP/Mg2+) in Tris buffer (20 mM Tris, 200 mM NaCl, 1 mM DTT, 0.01% Tween, pH 7.5). The assay demonstrated up to 5% DMSO tolerance and 0.96 Z’-factor, suggesting its robustness and suitability for high-throughput screening. Furthermore, the N-truncated peptides derived from uS11 C-terminus and the scrambled peptide inhibitors were evaluated, and the results confirmed the specificity and reliability of this assay for identifying inhibitors targeting hFap7-uS11 interaction.